Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and Australia
Author:
Publisher
Elsevier BV
Subject
Health Policy
Reference45 articles.
1. Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle;Taylor;The BMJ,2004
2. Crossing the fourth hurdle: crossing the fourth hurdle;Rawlins;British Journal of Clinical Pharmacology,2012
3. Which factors enhance positive drug reimbursement recommendation in Scotland? A retrospective analysis 2006–2013;Charokopou;Value in Health,2015
4. International comparison of comparative effectiveness research in five jurisdictions: insights for the US;Levy;PharmacoEconomics,2010
5. Federal Joint Committee, editor. Chapter 5: Benefit Assessment of pharmaceuticals according to s. 35a SGB V [Internet]. [cited 2015 June 29],2015
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. How Do the Institute for Clinical and Economic Review’s Assessments of Comparative Effectiveness Compare With the German Federal Joint Committee’s Assessments of Added Benefit? A Qualitative Study;Value in Health;2024-08
2. Pricing, Procurement and Reimbursement Policies for Incentivizing Market Entry of Novel Antibiotics and Diagnostics: Learnings from 10 Countries Globally;Applied Health Economics and Health Policy;2024-06-05
3. How can health technology assessment be improved to optimise access to medicines? Results from a Delphi study in Europe;The European Journal of Health Economics;2023-11-02
4. Shaping a suitable EU HTA dossier template: why the German template is not fit for purpose;The European Journal of Health Economics;2023-10-16
5. Health Technology Assessment–Informed Decision Making by the Federal Joint Committee/Institute for Quality and Efficiency in Health Care in Germany and the National Institute for Health and Care Excellence in England: The Role of Budget Impact;Value in Health;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3